All Access Articles |
- CG Oncology 10-K Report Reveals $379M Accumulated Deficit | 2026-02-27 | UNITED STATES
- CG Oncology Reports Q3 Financial Results | 2025-11-14 | BIOTECHNOLOGY
- CG Oncology Reports Q2 Financials - Cash Position Declines | 2025-08-08 | PHARMACEUTICAL
- CG Oncology Reports 75.5% Complete Response Rate in Bladder Cancer Study | 2025-04-28 | UNITED STATES
- CG Oncology Reports $88M Net Loss in 2024 | 2025-03-28 | UNITED STATES